Primary dysfunction in aggregation and secretion of SHRSP platelets: not secondary to the circulation of "exhausted" platelets.
The thrombin-induced secretion of [14C]-serotonin and adenine nucleotides from stroke-prone spontaneously hypertensive rats (SHRSP) platelets was markedly reduced with the development of hypertension accompanying hypo-aggregability compared with that from age-matched Wistar Kyoto rats (WKY) platelets. Calcium Ionophore A23187-induced secretion and aggregation were also attenuated in SHRSP platelets. Additionally, an enhancement of platelet secretion as well as aggregation by extracellular Ca2+ was less in SHRSP platelets than in WKY platelets. The platelet contents of adenine nucleotides and serotonin were not different between SHRSP and WKY at 5-16 weeks of age whereas they became significantly lower in SHRSP beginning at 22 weeks. The serotonin content in SHRSP platelets at 36 weeks of age was only 55% of that in WKY platelets. It is suggested that the reduced platelet aggregation and secretion observed in SHRSP platelets at ages lower than approximately 20 weeks are not secondary phenomena to the circulation of degranulated platelets, but the primary defect of SHRSP platelets appears to be an impaired function of Ca2+.
D000227:Adenine Nucleotides / Q000097:blood; D000367:Age Factors; D000818:Animals; D001792:Blood Platelets / Q000187:drug effects / Q000378:metabolism / Q000502:physiology*; D001794:Blood Pressure; D002135:Calcium-Binding Proteins / Q000494:pharmacology; D006973:Hypertension / Q000097:blood*; D008297:Male; D010974:Platelet Aggregation; D051381:Rats; D011918:Rats, Inbred SHR; D011919:Rats, Inbred Strains; D012701:Serotonin / Q000097:blood; D013268:Stimulation, Chemical; D013917:Thrombin / Q000494:pharmacology
D000227:Adenine Nucleotides; D002135:Calcium-Binding Proteins; C025673:calciphorin; D012701:Serotonin; D013917:Thrombin